866-997-4948(US-Canada Toll Free)

Nasal Polyps Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

Published By :

Transparency Market Research

Published Date : Aug 2019

Category :

Healthcare IT

No. of Pages : 168 Pages

A new study on the global nasal polyps treatment market was published by Transparency Market Research (TMR). It presents a wealth of information on the key market dynamics, including the drivers, market trends, and challenges, as well as the structure of the nasal polyps treatment market. TMR’s study offers valuable information about the nasal polyps treatment market, to illustrate how growth will discern during the forecast period of 2019–2027.

Key indicators of market growth, which include value chain as well as supply chain analysis, and Compound Annual Growth Rate (CAGR), are elucidated in TMR’s study in a comprehensive manner. This data can help readers interpret the quantitative growth aspects of the nasal polyps treatment market during the forecast period.

An extensive analysis on leading market players’ business strategies is also featured in TMR’s study on the nasal polyps treatment market. This can help readers understand principal factors to foresee growth in the nasal polyps treatment market. In this study, readers can also find specific data on the qualitative and quantitative growth avenues for the nasal polyps treatment market, which will guide market players in making apt decisions in the future.

Segmentation of the Nasal Polyps Treatment Market

TMR’s study on the nasal polyps treatment market includes information bifurcated into three sections - by type of treatment, by end user, and by region. Changing industry trends and other crucial market dynamics associated with these sections of the nasal polyps treatment market are discussed in detail.

Key Questions Answered in TMR’s Nasal Polyps Treatment Market Study

  • What is the scope of growth of nasal polyps treatment companies in the surgical treatment sector?
  • What will be the Y-o-Y growth of the nasal polyps treatment market between 2019 and 2027?
  • What is the influence of the changing trends in technologies on the nasal polyps treatment market?
  • Will North America continue to remain the most profitable regional market for nasal polyps treatment providers?
  • Which factors will impede the growth of the nasal polyps treatment market during the forecast period?
  • Which are the leading companies in the global nasal polyps treatment market?

Research Methodology

A unique research methodology is utilized by TMR to conduct comprehensive research on the growth of the nasal polyps treatment market, and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary resources referred to by analysts during the production of the nasal polyps treatment market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the nasal polyps treatment market, as a primary resource.

These primary and secondary resources provided exclusive information during the interviews, which serves as a validation from nasal polyps treatment industry leaders. Access to an extensive internal repository and external proprietary databases allows for this report to address specific details and questions about the nasal polyps treatment market with accuracy. The study also uses a top-down approach to assess the numbers for each segment, and a bottom-up approach to counter-validate them. This has helped in making TMR’s estimates on the future prospects of the nasal polyps treatment market more reliable and accurate.

Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Nasal Polyps Treatment Market

4. Market Overview

4.1. Introduction
4.1.1. Treatment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Nasal Polyps Treatment Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook
5.1. Key Industry Developments
5.2. Pipeline Analysis
5.3. Qualitative Assessment on Novel Treatment Options for Nasal Polyps: Biologics & Stents
5.3.1. Key Insights on Biologics (Xolair, Dupixent, Nucala) 

6. Global Nasal Polyps Treatment Market Analysis and Forecast, by Type of Treatment 
6.1. Introduction & Definition
6.2. Market Value Forecast, by Type of Treatment , 2017–2027
6.2.1. Pharmacological Therapies
6.2.1.1. Corticosteroids 
6.2.1.2. Antibiotics 
6.2.1.3. Leukotriene Inhibitors 
6.2.1.4. Others
6.2.2. Surgeries
6.2.2.1. Polypectomy 
6.2.2.2. Functional Endoscopic Sinus Surgery (FESS) 
6.3. Market Attractiveness By Type of Treatment 

7. Global Nasal Polyps Treatment Market Analysis and Forecast, by End-user 
7.1. Introduction & Definition
7.2. Market Value Forecast, by End-user, 2017–2027
7.2.1. Hospitals 
7.2.2. Ambulatory Surgical Centers 
7.2.3. Specialty Clinics 
7.3. Market Attractiveness, by End-user 

8. Global Nasal Polyps Treatment Market Analysis and Forecast, by Region
8.1. Introduction
8.2. Market Value Forecast, by Region
8.2.1. North America 
8.2.2. Europe 
8.2.3. Asia Pacific 
8.2.4. Latin America 
8.2.5. Middle East & Africa 
8.3. Market Attractiveness, by Country/Region

9. North America Nasal Polyps Treatment Market Analysis and Forecast
9.1. Introduction
9.2. Market Value Forecast, by Type of Treatment , 2017–2027
9.2.1. Pharmacological Therapies
9.2.1.1. Corticosteroids 
9.2.1.2. Antibiotics 
9.2.1.3. Leukotriene Inhibitors 
9.2.1.4. Others
9.2.2. Surgeries
9.2.2.1. Polypectomy 
9.2.2.2. Functional Endoscopic Sinus Surgery (FESS) 
9.3. Market Value Forecast, by End-user, 2017–2027
9.3.1. Hospitals 
9.3.2. Ambulatory Surgical Centers 
9.3.3. Specialty Clinics 
9.4. Market Value Forecast, by Country, 2017–2027
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis 
9.5.1. By Type of Treatment 
9.5.2. By End-user 
9.5.3. By Country

10. Europe Nasal Polyps Treatment Market Analysis and Forecast
10.1. Introduction
10.2. Market Value Forecast, by Type of Treatment , 2017–2027
10.2.1. Pharmacological Therapies
10.2.1.1. Corticosteroids 
10.2.1.2. Antibiotics 
10.2.1.3. Leukotriene Inhibitors 
10.2.1.4. Others
10.2.2. Surgeries
10.2.2.1. Polypectomy 
10.2.2.2. Functional Endoscopic Sinus Surgery (FESS) 
10.3. Market Value Forecast, by End-user, 2017–2027
10.3.1. Hospitals 
10.3.2. Ambulatory Surgical Centers 
10.3.3. Specialty Clinics 
10.4. Market Value Forecast, by Country/Sub-region, 2017–2027
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis 
10.5.1. By Type of Treatment 
10.5.2. By End-user 
10.5.3. By Country/Sub-region

11. Asia Pacific Nasal Polyps Treatment Market Analysis and Forecast
11.1. Introduction
11.2. Market Value Forecast, by Type of Treatment, 2017–2027
11.2.1. Pharmacological Therapies
11.2.1.1. Corticosteroids 
11.2.1.2. Antibiotics 
11.2.1.3. Leukotriene Inhibitors 
11.2.1.4. Others
11.2.2. Surgeries
11.2.2.1. Polypectomy 
11.2.2.2. Functional Endoscopic Sinus Surgery (FESS) 
11.3. Market Value Forecast, by End-user, 2017–2027
11.3.1. Hospitals 
11.3.2. Ambulatory Surgical Centers 
11.3.3. Specialty Clinics 
11.4. Market Value Forecast, by Country/Sub-region, 2017–2027
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis 
11.5.1. By Type of Treatment 
11.5.2. By End-user 
11.5.3. By Country/Sub-region

12. Latin America Nasal Polyps Treatment Market Analysis and Forecast
12.1. Introduction
12.2. Market Value Forecast, by Type of Treatment, 2017–2027
12.2.1. Pharmacological Therapies
12.2.1.1. Corticosteroids 
12.2.1.2. Antibiotics 
12.2.1.3. Leukotriene Inhibitors 
12.2.1.4. Others
12.2.2. Surgeries
12.2.2.1. Polypectomy 
12.2.2.2. Functional Endoscopic Sinus Surgery (FESS) 
12.3. Market Value Forecast, by End-user, 2017–2027
12.3.1. Hospitals 
12.3.2. Ambulatory Surgical Centers 
12.3.3. Specialty Clinics 
12.4. Market Value Forecast, by Country/Sub-region, 2017–2027
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis 
12.5.1. By Type of Treatment 
12.5.2. By End-user 
12.5.3. By Country/Sub-region

13. Middle East & Africa Nasal Polyps Treatment Market Analysis and Forecast
13.1. Introduction
13.2. Market Value Forecast, by Type of Treatment , 2017–2027
13.2.1. Pharmacological Therapies
13.2.1.1. Corticosteroids 
13.2.1.2. Antibiotics 
13.2.1.3. Leukotriene Inhibitors 
13.2.1.4. Others
13.2.2. Surgery 
13.2.2.1. Polypectomy 
13.2.2.2. Functional Endoscopic Sinus Surgery (FESS) 
13.3. Market Value Forecast, by End-user, 2017–2027
13.3.1. Hospitals 
13.3.2. Ambulatory Surgical Centers 
13.3.3. Specialty Clinics 
13.4. Market Value Forecast, by Country/Sub-region, 2017–2027
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis 
13.5.1. By Type of Treatment 
13.5.2. By End-user 
13.5.3. By Country/Sub-region

14. Competition Landscape
14.1. Market Player - Competition Matrix (By Tier and Size of companies)
14.2. Global Nasal Polyps Treatment Market Position Analysis, by Company, 2018
14.3. Company Profiles
14.3.1. OptiNose US, Inc.
14.3.2. Regeneron Pharmaceuticals, Inc.
14.3.3. Merck & Co., Inc.
14.3.4. Pfizer, Inc.
14.3.5. F. Hoffmann La-Roche, Ltd. 
14.3.6. Intersect ENT, Inc.
14.3.7. GlaxoSmithKline plc 
14.3.8. Sanofi
14.3.9. Novartis AG

List of Table

List of Tables

Table 01: Pipeline Analysis: Nasal Polyps
Table 02: Global Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Type of Treatment, 2017–2027
Table 03: Global Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Pharmacological Therapies, 2017–2027
Table 04: Global Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Surgeries, 2017–2027
Table 05: Global Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 06: Global Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 07: North America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 08: North America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Type of Treatment, 2017–2027
Table 09: North America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Pharmacological Therapies, 2017–2027
Table 10: North America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Surgeries, 2017–2027
Table 11: North America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by End-user, 2017?2027
Table 12: Europe Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 13: Europe Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Type of Treatment, 2017–2027
Table 14: Europe Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Pharmacological Therapies, 2017–2027
Table 15: Europe Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Surgeries, 2017–2027
Table 16: Europe Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by End-user, 2017?2027
Table 17: Asia Pacific Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 18: Asia Pacific Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Type of Treatment, 2017–2027
Table 19: Asia Pacific Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Pharmacological Therapies, 2017–2027
Table 20: Asia Pacific Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Surgeries, 2017–2027
Table 21: Asia Pacific Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by End-user, 2017?2027
Table 22: Latin America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 23: Latin America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Type of Treatment, 2017–2027
Table 24: Latin America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Pharmacological Therapies, 2017–2027
Table 25: Latin America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Surgeries, 2017–2027
Table 26: Latin America Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by End-user, 2017?2027
Table 27: Middle East & Africa Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 28: Middle East & Africa Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Type of Treatment, 2017–2027
Table 29: Middle East & Africa Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Pharmacological Therapies, 2017–2027
Table 30: Middle East & Africa Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by Surgeries, 2017–2027
Table 31: Middle East & Africa Nasal Polyps Treatment Market Value (US$ Mn) Forecast, by End-user, 2017?2027

List of Chart

List of Figures

Figure 01: Global Nasal Polyps Treatment Market Snapshot
Figure 02: Global Nasal Polyps Treatment Market Value (US$ Mn) and Distribution (%), by Region, 2019 and 2027
Figure 03: Global Nasal Polyps Treatment Market Value (US$ Mn) Forecast, 2017–2027
Figure 04: Global Nasal Polyps Treatment Market Value Share (%), by Type of Treatment, 2018
Figure 05: Global Nasal Polyps Treatment Market Value Share (%), by End-user, 2018
Figure 06: Global Nasal Polyps Treatment Market Value Share (%), by Region, 2018
Figure 07: Nasal Polyps Treatment Market - Collaborations, Partnerships & New Product Launch 
Figure 08: Global Nasal Polyps Treatment Market Value Share (%), by Type of Treatment, 2018 and 2027
Figure 09: Global Nasal Polyps Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pharmacological Therapies, 2017–2027
Figure 10: Global Nasal Polyps Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Surgeries, 2017–2027
Figure 11: Global Nasal Polyps Treatment Market Attractiveness, by Type of Treatment, 2019–2027
Figure 12: Global Nasal Polyps Treatment Market Value Share (%), by End-user, 2018 and 2027
Figure 13: Global Nasal Polyps Treatment Market Attractiveness, by End-user, 2019–2027
Figure 14: Global Nasal Polyps Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2027
Figure 15: Global Nasal Polyps Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ambulatory Surgical Centers, 2017–2027
Figure 16: Global Nasal Polyps Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Specialty Clinics, 2017–2027
Figure 17: Global Nasal Polyps Treatment Market Value Share Analysis, by Region, 2018 and 2027
Figure 18: Global Nasal Polyps Treatment Market Attractiveness Analysis, by Region, 2019–2027
Figure 19: North America Nasal Polyps Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 20: North America Nasal Polyps Treatment Market Value Share Analysis, by Country, 2018 and 2027
Figure 21: North America Nasal Polyps Treatment Market Attractiveness Analysis, by Country, 2019–2027
Figure 22: North America Nasal Polyps Treatment Market Value Share (%), by Type of Treatment, 2018 and 2027
Figure 23: North America Nasal Polyps Treatment Market Attractiveness, by Type of Treatment, 2019–2027
Figure 24: North America Nasal Polyps Treatment Market Value Share (%), by End-user, 2018 and 2027
Figure 25: North America Nasal Polyps Treatment Market Attractiveness, by End-user, 2019–2027
Figure 26: Europe Nasal Polyps Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 27: Europe Nasal Polyps Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 28: Europe Nasal Polyps Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 29: Europe Nasal Polyps Treatment Market Value Share (%), by Type of Treatment, 2018 and 2027
Figure 30: Europe Nasal Polyps Treatment Market Attractiveness, by Type of Treatment, 2019–2027
Figure 31: Europe Nasal Polyps Treatment Market Value Share (%), by End-user, 2018 and 2027
Figure 32: Europe Nasal Polyps Treatment Market Attractiveness, by End-user, 2019–2027
Figure 33: Asia Pacific Nasal Polyps Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 34: Asia Pacific Nasal Polyps Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 35: Asia Pacific Nasal Polyps Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 36: Asia Pacific Nasal Polyps Treatment Market Value Share (%), by Type of Treatment, 2018 and 2027
Figure 37: Asia Pacific Nasal Polyps Treatment Market Attractiveness, by Type of Treatment, 2019–2027
Figure 38: Asia Pacific Nasal Polyps Treatment Market Value Share (%), by End-user, 2018 and 2027
Figure 39: Asia Pacific Nasal Polyps Treatment Market Attractiveness, by End-user, 2019–2027
Figure 40: Latin America Nasal Polyps Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 41: Latin America Nasal Polyps Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 42: Latin America Nasal Polyps Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 43: Latin America Nasal Polyps Treatment Market Value Share (%), by Type of Treatment, 2018 and 2027
Figure 44: Latin America Nasal Polyps Treatment Market Attractiveness, by Type of Treatment, 2019–2027
Figure 45: Latin America Nasal Polyps Treatment Market Value Share (%), by End-user, 2018 and 2027
Figure 46: Latin America Nasal Polyps Treatment Market Attractiveness, by End-user, 2019–2027
Figure 47: Middle East & Africa Nasal Polyps Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 48: Middle East & Africa Nasal Polyps Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 49: Middle East & Africa Nasal Polyps Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 50: Middle East & Africa Nasal Polyps Treatment Market Value Share (%), by Type of Treatment, 2018 and 2027
Figure 51: Middle East & Africa Nasal Polyps Treatment Market Attractiveness, by Type of Treatment, 2019–2027
Figure 52: Middle East & Africa Nasal Polyps Treatment Market Value Share (%), by End-user, 2018 and 2027
Figure 53: Middle East & Africa Nasal Polyps Treatment Market Attractiveness, by End-user, 2019–2027
Figure 54: Global Nasal Polyps Treatment Market Position Analysis, by Top Company Ranking, 2018
Figure 55: OptiNose US, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 56: OptiNose US, Inc., R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 57: Regeneron Pharmaceuticals, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 58: Regeneron Pharmaceuticals, Inc. R&D Expenses (US$ Mn) & Y-o-Y Growth (%), 2015–2018
Figure 59: Regeneron Pharmaceuticals Inc., Breakdown of Net Sales (%), by Product, 2018
Figure 60: Merck & Co., Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 61: Merck & Co., Inc., Breakdown of Net Sales (%), by Business Segment, 2018
Figure 62: Merck & Co., Inc., Breakdown of Net Sales (%), by Region, 2018
Figure 63: Merck & Co., Inc., R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 64: Pfizer, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 65: Pfizer, Inc., Breakdown of Net Sales (%), by Business Segment, 2018
Figure 66: Pfizer, Inc., Breakdown of Net Sales (%), by Region, 2018
Figure 67: Pfizer, Inc., R&D Expenses (US$ Mn) & Y-o-Y Growth (%), 2015–2018
Figure 68: F. Hoffmann-La Roche, Ltd., Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 69: F. Hoffmann-La Roche, Ltd., Breakdown of Net Sales (%), by Business Segment, 2018
Figure 70: F. Hoffmann-La Roche, Ltd., Breakdown of Net Sales (%), by Region, 2018
Figure 71: F. Hoffmann-La Roche, Ltd., R&D Expenses (US$ Mn) & Y-o-Y Growth (%), 2015–2018
Figure 72: Intersect ENT, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 73: Intersect ENT, Inc., R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 74: GlaxoSmithKline plc, Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2018
Figure 75: GlaxoSmithKline plc, Breakdown of Net Sales (%), by Business Segment, 2018
Figure 76: GlaxoSmithKline plc, Breakdown of Net Sales (%), by Geography, 2018
Figure 77: GlaxoSmithKline plc, R&D Expenses (US$ Mn) & Y-o-Y Growth (%), 2015–2018
Figure 78: Sanofi, Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2018
Figure 79: Sanofi, Breakdown of Net Sales (%), by Business Segment, 2018
Figure 80: Sanofi, Breakdown of Net Sales (%), by Geography, 2018
Figure 81: Sanofi, R&D Expenses (US$ Mn) & Y-o-Y Growth (%), 2015–2018
Figure 82: Novartis AG, Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2018
Figure 83: Novartis AG, Breakdown of Net Sales (%), by Business Segment, 2018
Figure 84: Novartis AG, Breakdown of Net Sales (%), by Region, 2018
Figure 85: Novartis AG, R&D Expenses (US$ Mn) & Y-o-Y Growth (%), 2015–2018

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *